To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ArchiMed teams up with CDPQ to recap Corealis Pharma
ArchiMed has led the recapitalization of Corealis Pharma, a Laval, Quebec-based formulator and maker of solid dosage oral pharmaceuticals during pre-clinical and clinical pre-commercialization trials.
